Patients have slammed the PBAC for not accepting a streamlined process to accelerate funded patient access to immunotherapies.
-
Latest News
How many people will die because of this institutional indifference?
The most disheartening aspect of our HTA system is the lack of a straight-talking public critique by many with the influence to drive change. Ironically, Health Minister Mark Butler is responsible for the most compelling and effective recent critique of Australia's HTA decision-making.
-
Latest News Patients slam PBAC's failure to streamline cancer medicines access October 22, 2024
-
Latest News Moderna releases Winter report card highlighting the impact of respiratory illnesses October 22, 2024In the year to 6 October, 744,000 laboratory-confirmed cases of vaccine-preventable viral respiratory infections—RSV, influenza, and COVID-19—were reported, approximately 160,490 of which were in adults aged 65 and over.
-
Latest News Only those not confronting a life-ending diagnosis can view hope as intangible and false October 21, 2024It is a status quo outcome where an advisory committee, in not taking this opportunity, has denied more Australians the chance to avoid unnecessary suffering and preventable death. That is the practical consequence of this outcome.
-
Podcast The 'Week in Review' Podcast - 18 October October 18, 2024After a short break, we are back, and there is a lot to discuss. There are recommendations to fund unapproved and unapprovable therapeutic interventions, continued disappointment with newborn screening, and a proposed misinformation law significantly based on misinformation and an assumption that the government knows best.
-
Latest News Disappointment in response to status quo recommendation on new process October 21, 2024Disappointment for companies with the Pharmaceutical Benefits Advisory Committee rejecting their push for a simplified, streamlined process to reimburse immunotherapies.
-
Latest News Cancer and Cushing syndrome therapies secure positive recommendations October 21, 2024The Pharmaceutical Benefits Advisory Committee recommended a cancer therapy and a new treatment for Cushing's syndrome at its September meeting.
-
Latest News Auditor General launches audit of the procurement of onshore vaccine manufacturing facilities October 17, 2024The Auditor General has launched an audit to examine the effectiveness of the procurement and contract management of onshore vaccine manufacturing facilities.
-
Latest News The danger of this outlier is reflected in the disconnect with another policy process October 18, 2024The disconnect between the primary policy assumption underpinning the HTA Review, which is that products must be found safe and effective to be funded, demonstrates the extent of this MSAC outcome as a dangerous outlier.
-
Latest News Pharmac seeking bids from suppliers of COVID-19 vaccines October 17, 2024“We’re looking at our approach to the funding, eligibility, and procurement of these vaccines to align with other vaccines that we fund and so we can continue keeping New Zealanders well,” said Pharmac chief executive Sarah Fitt.
-
Latest News New research uncovers Australian women are often reluctant to openly talk about menopause October 18, 2024New research shows that despite 82 per cent of women who have experienced menopause symptoms reporting impacts on their quality of life, many do not feel comfortable openly talking about what they are experiencing.
-
Podcast TrailblAZers speaks with primary care leader and researcher October 17, 2024In its latest episode, TrailblAZers speaks with Professor Charlotte Hespe AM, the head of General Practice and Primary Care Research at Notre Dame University's School of Medicine.
-
Latest News This has happened before and the response should be the same. No. October 17, 2024The government could save billions by circumventing the regulatory process and funding unapproved health interventions. Of course, it does not do this because of the obvious risk to patient safety and public confidence in the health system. Why now?
-
Latest News Disappointment as TGA goes public early on anticipated Alzheimer's therapy October 16, 2024The company said, "The outcome of the initial stage of an evaluation is not routinely communicated to the public whilst the TGA review process is ongoing, as it has been with lecanemab."
-
Latest News Biogen awarded 'Great Place to Work' certification for 2024 October 17, 2024David Henderson, the managing director for Biogen Australia and New Zealand, said, “This certification is more than just an accolade; it’s a reflection of our collective effort in creating a workplace where every voice is heard."
-
Latest News Commercial Eyes signs new AI-focused service agreement with Opyl October 17, 2024Tanya van der Wall, country managing director of Commercial Eyes, said, “We are excited to collaborate with Opyl and leverage their advanced AI capabilities to enhance the innovative data-driven insights we provide to our clients."
-
Latest News Funding unapproved copies would fundamentally change our system - it can't be allowed to happen October 16, 2024In debating the right and wrong of public hospitals cooking up copies of approved nuclear medicine therapies, this country must contemplate the broader consequences, including of any funding decision.
-
Latest News Mark Butler needs to understand the implications of accepting this recommendation October 15, 2024Health Minister Mark Butler is now considering funding a copy of a therapy, which the TGA has not and probably cannot lawfully consider, let alone approve.
-
Latest News AusBiotech calling on experts to become mentors for Industry Growth Program October 15, 2024AusBiotech is seeking mentors to guide and support up-and-coming startups as they navigate the commercialisation pipeline.
Australian Biotech
-
US FDA grants rare paediatric designation to PYC's drug development program
October 21, 2024 -
Nyrada says it has completed safety studies ahead of Phase 1 clinical trial
October 16, 2024 -
AusBiotech calling on experts to become mentors for Industry Growth Program
October 15, 2024 -
Amplia Therapeutics CEO shares Prime Minister's Prize for Innovation
October 10, 2024 -
TGA approves new indication for Telix’s Illuccix to include patient selection for PSMA-targeted therapy
October 9, 2024
Other Health
-
Medibank expands four-day work week trial to 500 employees
October 9, 2024 -
Artrya submits application for Salix to the US FDA
September 30, 2024 -
'Australia’s child vaccination rates are world-leading. Our adult rates are not.'
August 19, 2024 -
HCF Research Foundation hosts roundtable to advance short stay joint replacements
July 22, 2024 -
Bupa Ventures to invest $20m to accelerate healthcare innovations
February 12, 2024
Latest Video
New Stories
-
How many people will die because of this institutional indifference?
October 22, 2024 - - Latest News -
Patients slam PBAC's failure to streamline cancer medicines access
October 22, 2024 - - Latest News -
Moderna releases Winter report card highlighting the impact of respiratory illnesses
October 22, 2024 - - Latest News -
Alcon supports future optometrists through new educational grant
October 21, 2024 - - Latest News -
US FDA grants rare paediatric designation to PYC's drug development program
October 21, 2024 - - Australian Biotech -
Only those not confronting a life-ending diagnosis can view hope as intangible and false
October 21, 2024 - - Latest News -
Disappointment in response to status quo recommendation on new process
October 21, 2024 - - Latest News